Quarterly report [Sections 13 or 15(d)]

Warrants

v3.26.1
Warrants
 3 Months Ended
Mar. 31, 2026
Warrants  
Warrants

Note 16: Warrants

 

The following table summarizes the activity in the Company’s outstanding warrants during the three months ended March 31, 2026:

                       
    Warrants     Weighted-Average Remaining Contractual Life     Weighted-Average Exercise Price per Share  
Outstanding at December 31, 2025     41,622,504       2.86     $ 1.52  
Granted     –       –       –  
Exercised     –       –       –  
Expired     (1,662,500 )     –       23.70  
Forfeitures     –       –       –  
Outstanding at March 31, 2026     39,960,004       2.77     $ 0.60  
                         
Exercisable at March 31, 2026     39,960,004       2.77     $ 0.60  

 

All outstanding warrants are classified as equity instruments in the Company's consolidated balance sheet, as the warrants meet the criteria for equity classification under ASC 815-40. During the three months ended March 31, 2026, the Company did not grant, exercise, or forfeit any warrants.